Change in mononuclear leukocyte responsiveness in midpregnancy and subsequent preterm birth

Obstetrics and Gynecology

Volumn 121, Issue 4, 2013, Pages 805-811

  Harper, Margaret ^a   Li, Liwu ^a   Zhao, Yuan ^a   Klebanoff, Mark A ^a   Thorp, John M ^a   Sorokin, Yoram ^a   Varner, Michael W ^a   Wapner, Ronald J ^a   Caritis, Steve N ^a   Iams, Jay D ^a   Carpenter, Marshall W ^a   Peaceman, Alan M ^a   Mercer, Brian M ^a   Sciscione, Anthony ^a   Rouse, Dwight J ^a   Ramin, Susan M ^a   Anderson, Garland D ^a  

^a not available   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; LIPOPOLYSACCHARIDE; OMEGA 3 FATTY ACID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CYTOKINE PRODUCTION; FEMALE; FISH MEAT; FOLLOW UP; GESTATION PERIOD; GESTATIONAL AGE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; MAJOR CLINICAL STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SECOND TRIMESTER PREGNANCY;

EID: 84876242574     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3182878a80     Document Type: Article

References (42)

1. Gomez R, Ghezzi F, Romero R, Munoz H, Tolosa JE, Rojas I. Premature labor and intra-amniotic infection. Clinical aspects and role of cytokines in diagnosis and pathophysiology. Clin Perinatol 1995; 22: 281-342.
2. Keelan JA, Blumenstein M, Helliwell RJ, Sato TA, Marvin KW, Mitchell MD. Cytokines, prostaglandins and parturition - a review. Placenta 2003; 24:S33-46.
3. Romero R, Espinoza J, Gonçalves LF, Kusanovic JP, Friel L, Hassan S. The role of inflammation and infection in preterm birth. Semin Reprod Med 2007; 25: 21-39.
4. Bastek JA, Gómez LM, Elovitz MA. The role of inflammation and infection in preterm birth. Clin Perinatol 2011; 38: 385-406.
5. Darby MI, Caritis SN, Shen-Schwartz S. Placental abruption in the preterm gestation: an association with chorioamnionitis. Obstet Gynecol 1989; 74: 88-92.
6. Lockwood CJ, Toti P, Arcuri F, Paidas M, Buchwalder L, Krikum G, et al. Mechanisms of abruption-induced premature rupture of the fetal membranes: thrombin-enhanced interleukin-8 expression in term decidua. Am J Pathol 2005; 167: 1443-9.
7. Romero R, Gonzalez R, Sepulveda W, Brandt F, Ramirez M, Sorokin Y, et al. Infection and labor: VIII. Microbial invasion of the amniotic cavity in patients with suspected cervical incompetence: prevalence and clinical significance. Am J Obstet Gynecol 1992; 167: 1086-91.
8. Bytautiene E, Romero R, Vedernikoy YP, El-Zeky F, Saade GR, Garfield RE. Induction of premature labor by allergic reaction and prevention by histamine H1 receptor antagonist. Am J Obstet Gynecol 2004; 191: 1356-61.
9. Peltier MR. Immunology of term and preterm labor. Reprod Biol Endocrinol 2003; 1: 122.
10. Krasnow JS, Tollerud DJ, Naus G, DeLoia JA. Endometrial Th2 cytokine expression throughout the menstrual cycle and early pregnancy. Hum Reprod 1996; 11: 1747-54.
11. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today 1993; 14: 353-6.
12. Sadowsky DW, Novy MF, Witkin SS, Gravett MG. Dexamethasone or interleukin-10 blocks interleukin-1 beta-induced uterine contractions in pregnant rhesus monkeys. Am J Obstet Gynecol 2003; 188: 252-63.
13. Terrone DA, Rinehart BK, Granger JP, Barrilleaux PS, Martin JN Jr, Bennett WA. Interleukin-10 administration and bacterial endotoxin-induced preterm birth in a rat model. Obstet Gynecol 2001; 98: 476-80.
14. Rodts-Palenik S, Wyatt-Ashmead J, Pang Y, Thigpen B, Cal Z, Rhodes P, et al. Maternal infection-induced white matter injury is reduced by treatment with interleukin-10. Am J Obstet Gynecol 2004; 191: 1387-92.
15. Hanna N, Hanna I, Hleb M, Wagner E, Dougherty J, Balkundi D, et al. Gestational age-dependent expression of IL-10 and its receptor in human placental tissues and isolated cytotrophoblasts. J Immunol 2000; 164: 5721-8.
16. Crider KS, Whitehead N, Buus RM. Genetic variation associated with preterm birth: a HuGE review. Genet Med 2005; 7: 593-604.
17. Bhattacharya S, Raja EA, Mirazo ER, Campbell DM, Lee AJ, Norman JE, et al. Inherited predisposition to spontaneous preterm delivery. Obstet Gynecol 2010; 115: 1125-33.
18. Pontes-Arruda A, Aragao AM, Albuquerque JD. Effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit Care Med 2006; 34: 2325-33.
19. Marik PE, Zaloga GP. Immunonutrition in critically ill patients: a systematic review and analysis of the literature. Intensive Care Med 2008; 34: 1980-90.
20. Hao W, Wong OY, Liu X, Lee P, Chen Y, Wong KK. v-3 fatty acids suppress inflammatory cytokine production by macrophages and hepatocytes. J Pediatr Surg 2010; 45: 2412-8.
21. Meydani SN, Endres S, Woods MM, Goldin BR, Soo C, MorrillLabrode A, et al. Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. J Nutr 1991; 121: 547-55.
22. Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JWM, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989; 320: 265-71.
23. Harper M, Thom E, Klebanoff M, Thorp J Jr, Sorokin Y, Varner M, et al. Omega-3 fatty acid supplementation to prevent recurrent preterm birth. Obstet Gynecol 2010; 115: 234-42.
24. Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, et al. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003; 348: 2379-85.
25. Willet WC, Sampson L, Stamper MJ, Rosner B, Bain C, Witschi J, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985; 122: 51-65.
26. Li L, Cousart S, Hu J, McCall CE. Characterization of interleukin-1 receptor associated kinase in normal and endotoxin-tolerant cells. J Biol Chem 2000; 275: 23340-5.
27. Li T, Hu J, Li L. Characterization of Tollip protein upon lipopolysaccharide challenge. Mol Immunol 2004; 41: 85-92.
28. Zimmerman DW. A note on consistency of non-parametric rank tests and related rank transformations. Br J Math Stat Psychol 2012; 65: 122-44.
29. Klebanoff MA, Harper M, Lai Y, Thorp J Jr, Sorokin Y, Varner MW, et al. Fish consumption, erythrocyte fatty acids, and preterm birth. Obstet Gynecol 2011; 117: 1071-7.
30. Hanna N, Bonifacio L, Weinberger B, Reddy P, Murphy S, Romero R, et al. Evidence for interleukin-10 mediated inhibition of cyclo-oxygenage-2 expression and prostaglandin production in preterm human placenta. Am J Reprod Immunol 2006; 55: 19-27.
31. Romero R, Espinoza J, Kusanovic JP, Gotsch F, Hassan S, Erez O, et al. The preterm parturition syndrome. BJOG 2006; 113(suppl 3): 17-42.
32. Warstedt K, Furuhjelm C, Duchén K, Fälth-Magnusson K, Fageräs M. The effects of omega-3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine and chemokine secretion. Pediatr Res 2009; 66: 212-7.
33. Vega-Lopez S, Kaul N, Devaraj S, Cai RY, German B, Jialal I. Supplementation with omega3 polyunsaturated fatty acids and all-rac alpha-tocopherol alone and in combination failed to exert an anti-inflammatory effect in human volunteers. Metabolism 2004; 53: 236-40.
34. Fujioka S, Hamazaki K, Itomura M, Huan M, Nishizawa H, Sawazaki S, et al. The effects of eicosapentaenoic acid-fortified food on inflammatory markers in healthy subjects - a randomized, placebo controlled, double-blind study. J Nutr Sci Vitaminol 2006; 52: 261-5.
35. Lee KW, Blann AD, Lip GY. Effects of omega-3 polyunsaturated fatty acids on plasma indices of thrombogenesis and inflammation in patients post-myocardial infarction. Thromb Res 2006; 118: 305-12.
36. Browning LM, Krebs JD, Moore CS, Mishra GD, O'Connell MA, Jebb SA. The impact of long chain n-3 polyunsaturated fatty acid supplementation on inflammation, insulin sensitivity and CVD risk in a group of overweight women with an inflammatory phenotype. Diabetes Obes Metab 2007; 9: 70-80.
37. Schiano V, Laurenzano E, Brevetti G, De Maio JI, Lanero S, Scopacasa F, et al. Omega-3 polyunsaturated fatty acid in peripheral arterial disease: effect on lipid pattern, disease severity, inflammation profile, and endothelial function. Clin Nutr 2008; 27: 241-7.
38. Yusof HM, Miles EA Calder PC. Influence of very long-chain n-3 fatty acids on plasma markers of inflammation in middleaged men. Prostaglandins Leukot Essent Fatty Acids 2008; 78: 219-28.
39. de Roos B, Mavrommatis Y, Brouwer IA. Long-chain n-3 polyunsaturated fatty acids: new insights into mechanisms relating to inflammation and coronary heart disease. Br J Pharmacol 2009; 158: 413-28.
40. Stites DP, Siiteri PK. Steroids as immunosuppressants in pregnancy. Immunol Rev 1983; 75: 117-38.
41. Siiteri PK Stites DP. Immunologic and endocrine interrelationships in pregnancy. Biol Reprod 1982; 26: 1-14.
42. Hansen PJ. Regulation of uterine immune function by progesterone-lessons from the sheep. J Reprod Immunol 1998; 40: 63-79.